COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase

Christiane Mühle; Andreas Kremer; Marcel Vetter; Jonas Schmid; Susanne Achenbach; Fabian Schumacher; Bernd Lenz; Céline Cougoule; Nicolas Hoertel; Alexander Carpinteiro; Erich Gulbins; Burkhard Kleuser; Johannes Kornhuber

doi:10.1101/2022.01.19.22269391

Article Information

doi

https://doi.org/10.1101/2022.01.19.22269391

History

January 23, 2022.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

Christiane Mühle1,*,
Andreas Kremer2,3,
Marcel Vetter2,
Jonas Schmid2,
Susanne Achenbach4,
Fabian Schumacher5,
Bernd Lenz6,
Céline Cougoule7,
Nicolas Hoertel8,
Alexander Carpinteiro9,10,
Erich Gulbins10,
Burkhard Kleuser5 and
Johannes Kornhuber1

¹Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany
²Department of Medicine 1, Universitätsklinikum Erlangen and Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany
³Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland
⁴Department of Transfusion Medicine, Universitätsklinikum Erlangen and Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany
⁵Freie Universität Berlin, Institute of Pharmacy, Königin-Luise-Str. 2+4, 14195 Berlin, Germany
⁶Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Germany
⁷Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France
⁸Université de Paris, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Département de Psychiatrie, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France
⁹Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
¹⁰Institute for Molecular Biology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany

↵*Corresponding author at: Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, D-91054 Erlangen, Germany., Phone: +49 9131 85-44738, Fax: +49 9131 85-36381, E-Mail: christiane.muehle{at}uk-erlangen.de, christiane.muehle{at}molbio-research.eu